CIK: 0001595851 · Show all filings
Period: Q4 2016 (← Previous) (Next →)
Filing Date: Feb 14, 2017
Total Value: $415M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| XBI | SPDR SERIES TRUST | 600,000 | $35.51M | 8.5% | $59.19 | — | — | Put | 78464A870 |
| — | SHIRE PLC | 100,000 | $17.04M | 4.1% | $170.38 | $170.38 | — | SPONSORED ADR | 82481R106 |
| ABT | ABBOTT LABS | 400,000 | $15.36M | 3.7% | $38.41 * | $35.51 | -5.3% | COM | 002824100 |
| — | ALEXION PHARMACEUTICALS INC | 115,000 | $14.07M | 3.4% | $122.35 | $125.69 | — | COM | 015351109 |
| ZBH | ZIMMER BIOMET HLDGS INC | 130,000 | $13.42M | 3.2% | $103.20 * | $113.85 | -12.7% | COM | 98956P102 |
| MRK | MERCK & CO INC | 225,000 | $13.25M | 3.2% | $58.87 * | $44.08 | 0.0% | COM | 58933Y105 |
| — | CELGENE CORP | 110,000 | $12.73M | 3.1% | $115.75 | $104.54 | — | COM | 151020104 |
| — | DBV TECHNOLOGIES S A | 325,000 | $11.42M | 2.7% | $35.13 | $36.05 | — | SPONSORED ADR | 23306J101 |
| — | SAGE THERAPEUTICS INC | 200,000 | $10.21M | 2.5% | $51.06 | $46.68 | — | COM | 78667J108 |
| — | NUVASIVE INC | 150,000 | $10.1M | 2.4% | $67.36 | $57.34 | — | COM | 670704105 |
| ACAD | ACADIA PHARMACEUTICALS INC | 350,000 | $10.09M | 2.4% | $28.84 * | $33.90 | -22.0% | Call | 004225108 |
| — | CLOVIS ONCOLOGY INC | 220,000 | $9.772M | 2.4% | $44.42 | $16.16 | — | COM | 189464100 |
| BSX | BOSTON SCIENTIFIC CORP | 450,000 | $9.734M | 2.3% | $21.63 | $19.09 | +14.3% | COM | 101137107 |
| BMY | BRISTOL MYERS SQUIBB CO | 150,000 | $8.766M | 2.1% | $58.44 * | $39.53 | 0.0% | Call | 110122108 |
| — | AVEXIS INC | 175,000 | $8.353M | 2.0% | $47.73 | $46.75 | — | COM | 05366U100 |
| — | SPECTRANETICS CORP | 335,000 | $8.208M | 2.0% | $24.50 | $15.14 | — | COM | 84760C107 |
| — | SEATTLE GENETICS INC | 150,000 | $7.916M | 1.9% | $52.77 | $52.77 | — | COM | 812578102 |
| ABT | ABBOTT LABS | 200,000 | $7.682M | 1.8% | $38.41 * | $35.51 | -5.3% | Call | 002824100 |
| — | INTERCEPT PHARMACEUTICALS IN | 70,000 | $7.606M | 1.8% | $108.66 | $108.66 | — | COM | 45845P108 |
| — | NEURODERM LTD | 330,000 | $7.326M | 1.8% | $22.20 | $20.73 | — | ORD SHS | M74231107 |
| BCRX | BIOCRYST PHARMACEUTICALS | 1,150,000 | $7.28M | 1.8% | $6.33 * | $3.15 | +64.9% | COM | 09058V103 |
| GKOS | GLAUKOS CORP | 200,000 | $6.86M | 1.7% | $34.30 | $34.23 | 0.0% | COM | 377322102 |
| — | LION BIOTECHNOLOGIES INC | 975,000 | $6.776M | 1.6% | $6.95 | $7.17 | — | COM | 53619R102 |
| — | MALLINCKRODT PUB LTD CO | 135,000 | $6.726M | 1.6% | $49.82 | $49.82 | — | SHS | G5785G107 |
| — | AERIE PHARMACEUTICALS INC | 175,000 | $6.624M | 1.6% | $37.85 | $37.77 | — | COM | 00771V108 |
| — | NEVRO CORP | 90,000 | $6.539M | 1.6% | $72.66 | $69.48 | — | COM | 64157F103 |
| BSX | BOSTON SCIENTIFIC CORP | 300,000 | $6.489M | 1.6% | $21.63 | $19.09 | +14.3% | Call | 101137107 |
| — | IMMUNOMEDICS INC | 1,700,000 | $6.239M | 1.5% | $3.67 | $2.79 | — | COM | 452907108 |
| PBYI | PUMA BIOTECHNOLOGY INC | 200,000 | $6.14M | 1.5% | $30.70 * | $50.56 | -14.5% | Call | 74587V107 |
| — | FLAMEL TECHNOLOGIES SA | 575,000 | $5.974M | 1.4% | $10.39 | $11.39 | — | SPONSORED ADR | 338488109 |
| BMY | BRISTOL MYERS SQUIBB CO | 100,000 | $5.844M | 1.4% | $58.44 * | $39.53 | 0.0% | COM | 110122108 |
| AGIO | AGIOS PHARMACEUTICALS INC | 140,000 | $5.842M | 1.4% | $41.73 * | $52.47 | 0.0% | COM | 00847X104 |
| PRGO | PERRIGO CO PLC | 70,000 | $5.826M | 1.4% | $83.23 * | $86.74 | 0.0% | SHS | G97822103 |
| — | EPIZYME INC | 475,000 | $5.748M | 1.4% | $12.10 | $12.10 | — | COM | 29428V104 |
| — | NANOSTRING TECHNOLOGIES INC | 250,000 | $5.575M | 1.3% | $22.30 | $15.45 | — | COM | 63009R109 |
| SRPT | SAREPTA THERAPEUTICS INC | 200,000 | $5.486M | 1.3% | $27.43 * | $18.47 | +117.5% | Call | 803607100 |
| — | CURRENCYSHARES SWISS FRANC T | 46,400 | $4.349M | 1.0% | $93.73 | $93.73 | — | SWISS FRANC SH | 23129V109 |
| BIIB | BIOGEN INC | 15,000 | $4.254M | 1.0% | $283.60 * | $263.54 | +12.5% | COM | 09062X103 |
| — | ENDO INTL PLC | 250,000 | $4.118M | 1.0% | $16.47 | $16.47 | — | SHS | G30401106 |
| — | FOAMIX PHARMACEUTICALS LTD | 365,000 | $4.052M | 1.0% | $11.10 | $10.31 | — | SHS | M46135105 |
| — | WRIGHT MED GROUP N V | 175,000 | $4.022M | 1.0% | $22.98 | $22.32 | — | ORD SHS 0.03 PAR | N96617118 |
| — | SPARK THERAPEUTICS INC | 80,000 | $3.992M | 1.0% | $49.90 | $49.90 | — | COM | 84652J103 |
| — | ENTELLUS MED INC | 200,000 | $3.794M | 0.9% | $18.97 | $19.06 | — | COM | 29363K105 |
| — | QIAGEN NV | 135,000 | $3.783M | 0.9% | $28.02 | $27.44 | — | REG SHS | N72482107 |
| — | AQUINOX PHARMACEUTICALS INC | 225,000 | $3.715M | 0.9% | $16.51 | $13.36 | — | COM | 03842B101 |
| IRTC | IRHYTHM TECHNOLOGIES INC | 115,182 | $3.455M | 0.8% | $30.00 * | $26.94 | 0.0% | COM | 450056106 |
| ACRS | ACLARIS THERAPEUTICS INC | 120,000 | $3.257M | 0.8% | $27.14 * | $21.22 | +20.2% | COM | 00461U105 |
| ACAD | ACADIA PHARMACEUTICALS INC | 100,000 | $2.884M | 0.7% | $28.84 * | $33.90 | -22.0% | COM | 004225108 |
| IRIX | IRIDEX CORP | 200,000 | $2.812M | 0.7% | $14.06 | $14.20 | 0.0% | COM | 462684101 |
| — | ZOGENIX INC | 225,000 | $2.734M | 0.7% | $12.15 | $11.43 | — | COM NEW | 98978L204 |
| — | MEDICINES CO | 75,000 | $2.546M | 0.6% | $33.95 | $33.95 | — | COM | 584688105 |
| XENE | XENON PHARMACEUTICALS INC | 325,000 | $2.503M | 0.6% | $7.70 * | $7.72 | +4.0% | COM | 98420N105 |
| — | TESARO INC | 17,000 | $2.286M | 0.6% | $134.47 | $84.06 | — | COM | 881569107 |
| — | HORIZON PHARMA PLC | 129,100 | $2.089M | 0.5% | $16.18 | $16.57 | — | Call | G4617B105 |
| — | BLUEBIRD BIO INC | 30,000 | $1.851M | 0.4% | $61.70 | $43.29 | — | COM | 09609G100 |
| — | INOTEK PHARMACEUTICALS CORP | 300,000 | $1.83M | 0.4% | $6.10 | $9.48 | — | Call | 45780V102 |
| — | RIGEL PHARMACEUTICALS INC | 700,000 | $1.666M | 0.4% | $2.38 | $2.23 | — | COM NEW | 766559603 |
| VCYT | VERACYTE INC | 200,000 | $1.548M | 0.4% | $7.74 * | $8.25 | -9.4% | COM | 92337F107 |
| INCY | INCYTE CORP | 13,000 | $1.304M | 0.3% | $100.31 * | $97.56 | 0.0% | COM | 45337C102 |
| — | RA PHARMACEUTICALS INC | 75,000 | $1.139M | 0.3% | $15.19 | $15.19 | — | COM | 74933V108 |
| — | ALCOBRA LTD | 500,000 | $1.05M | 0.3% | $2.10 | $3.95 | — | SHS | M2239P109 |
| — | ACCELERON PHARMA INC | 40,000 | $1.021M | 0.2% | $25.52 | $25.52 | — | COM | 00434H108 |
| — | VTV THERAPEUTICS INC | 200,000 | $966K | 0.2% | $4.83 | $4.83 | — | CL A | 918385105 |
| — | ARIAD PHARMACEUTICALS INC | 75,000 | $933K | 0.2% | $12.44 | $12.44 | — | COM | 04033A100 |
| — | MIRATI THERAPEUTICS INC | 172,184 | $818K | 0.2% | $4.75 | $13.43 | — | COM | 60468T105 |
| VNDA | VANDA PHARMACEUTICALS INC | 46,000 | $734K | 0.2% | $15.96 | $13.46 | +19.4% | COM | 921659108 |
| — | OPHTHOTECH CORP | 86,100 | $416K | 0.1% | $4.83 | — | — | Call | 683745103 |
| — | ACORDA THERAPEUTICS INC | 20,000 | $376K | 0.1% | $18.80 | $25.50 | — | COM | 00484M106 |
| — | SYNERGY PHARMACEUTICALS DEL | 55,000 | $335K | 0.1% | $6.09 | $4.83 | — | COM NEW | 871639308 |
| — | AKARI THERAPEUTICS PLC | 46,622 | $328K | 0.1% | $7.04 | $18.60 | — | SPONSORED ADR | 00972G108 |